Kyle Kline sold $363k of GMED
Senior Vice President, CFO at GLOBUS MEDICAL INC. 3,594 shares at an average of $101.10, traded Jan 8, 2026, filed Jan 12, 2026.
Score components
- +22RoleCFO
- +15Trade size$363k at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.8%, 3m +1.4%, 6m -13.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-010699, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 8, 2026 | MOption exercise Class A Common Stock10b5-1 | +3,594 | $51.87 | $186k | 3,594 | Jan 12, 2026 |
| Jan 8, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -3,594 | $101.10 | $363k | 0 | Jan 12, 2026 |
| Jan 8, 2026 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -3,594 | $0.00 | $0 | 3,906 | Jan 12, 2026 |
Related signals
Other insiders at GLOBUS MEDICAL INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | GMEDsell GLOBUS MEDICAL INC | James R Tobin director | $2.2M 30,000 shares | -100% | |
| 45Moderate | GMEDsell GLOBUS MEDICAL INC | Stephen T Zarrilli director | $2.2M 25,000 shares | -100% | |
| 25Weak | GMEDsell GLOBUS MEDICAL INC | David D Davidar director | $2.0M 25,000 shares | -5% | |
| 25Weak | GLOBUS MEDICAL INC | Kelly Huller EVP, GC, Corporate Secretary | $1.9M 20,000 shares | -100% | |
| 23Weak | GLOBUS MEDICAL INC | Kelly Huller EVP, GC, Corporate Secretary | $877k 10,000 shares | -100% | |
| 20Weak | GLOBUS MEDICAL INC | Leslie Norwalk V director | $202k 2,000 shares | -16% | |
| 23Weak | GLOBUS MEDICAL INC | Leslie Norwalk V director | $355k 4,000 shares | -24% | |
| 47Moderate | GLOBUS MEDICAL INC | Kyle Kline Senior Vice President, CFO | $1.7M 18,542 shares | -100% | |
| 35Weak | GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $675k 7,500 shares | -100% | |
| 40Moderate | GLOBUS MEDICAL INC | David D Davidar director | $2.2M 25,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.